Injectable soft-tissue augmentation agents have become popular alternatives to surgical
procedures for the aging face and body. In contrast to temporary, space-occupying replacement …

Objective To identify, describe, and classify the main skin manifestations of COVID-19 and
associated protocols for management. Methods Forty-five patients from three clinical centers …

Background Poly-l-lactic acid (PLLA) is an injectable volumizer with biostimulatory properties
used for volumetric structural rejuvenation in patients with facial fat volume loss but has …

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose
oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and …

Hair loss in women, also known as female pattern hair loss (FPHL), is a common form of
nonscarring hair loss that affects around 20% of adult women in the United States. It is …

a plethora of energy-based technologies are available for this indication. Radiofrequency,
ultrasound, and shockwave devices have shown positive results in improving the elasticity …

Androgenetic alopecia (AGA) in men and women is the most common cause of hair loss.
Affected individuals may experience psychological distress and social withdrawal. Current …

Background Dyschromia is one of the most common reasons for patients to seek dermatological
care, especially among individuals with skin of color. Most cases present as melasma or …

Photoaging due to cumulative lifetime ultraviolet light exposure is the greatest contributing
factor to facial aging. With the continued growth of the population of individuals aged≥ 65 …

Background Skin rejuvenation can be achieved with minimally invasive treatments using
energy-based devices that feature reduced side effects and downtime. Post-treatment care is …